地球仪
透视图(图形)
医学
重症监护医学
造血细胞
移植
外科
计算机科学
造血
干细胞
生物
人工智能
遗传学
眼科
作者
Riad El Fakih,Hillard M. Lazarus,Lori Muffly,Majed Altareb,Mahmoud Aljurf,Shahrukh K. Hashmi
出处
期刊:Blood Reviews
[Elsevier BV]
日期:2021-10-19
卷期号:52: 100892-100892
被引量:2
标识
DOI:10.1016/j.blre.2021.100892
摘要
The hematopoietic cell transplantation practice has changed significantly over the years. More than 1500 centers around the globe are offering transplant for different types of diseases. This growth was driven by improving the efficacy and the safety of the procedure and the ability to use alternate donors. These improvements made the procedure feasible in virtually all patients in need for it. With the availability of novel therapies and targeted agents, we may be witnessing a new transplant-era. These agents may help to circumvent some of the remaining limitations of the procedure and open the doors for new indications. Herein, we review historical transplant milestones, the accomplishments that led to the modern transplant practice and we discuss the idea of minimal-intensity conditioning and the possibility to adopt chemotherapy and radiation-free preparative regimens in the near future.
科研通智能强力驱动
Strongly Powered by AbleSci AI